Navigation Links
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
Date:12/17/2009

es and other governmental regulatory bodies, including the FDA's review of any filings we make in connection with the treatment protocol; delays in the FDA's or other health regulatory authorities' approval of any applications we file or refusals to approve such filings; refusals by such regulatory authorities to approve the marketing and sale of a drug product even after acceptance of an application we file for any such drug product; the identification of lead compounds; the risk that we may fail to satisfy certain conditions relating to grants we have received from the Office of the Chief Scientist of Israel's Ministry of Industry and Trade which may lead to our being required to refund grants previously received together with interest and penalties; the risk that the Office of the Chief Scientist may not deliver to us all of the funds awarded to us; uncertainties related to the ability to attract and retain partners for our technologies and products under development; and other factors described in our filings with the Securities and Exchange Commission. Companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced or late-stage clinical trials, even after obtaining promising earlier trial results or in preliminary findings for such clinical trials. Further, even if favorable testing data is generated by clinical trials of drug products, the FDA may not accept or approve an NDA filed by a pharmaceutical or biotechnology company for such drug product. Failure to obtain FDA approval of any of our drug candidates in a timely manner, if at all, will severely undermine our business and results of operation by reducing our potential marketable products and our ability to generate corresponding product revenues. Under our approved treatment protocol, taliglucerase alfa might be provided only to a limited number of patients and only for a limited time. The FDA's approval of the treatment protocol or the fast track design
'/>"/>
SOURCE Protalix BioTherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
2. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
3. CVS Caremark Names New Chief Human Resources Officer
4. Cardinal Health Names Carrie Cox to Board of Directors
5. Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO
6. The Deal Names Abbott Top Dealmaker for Second Consecutive Year
7. IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
8. AMD LASERS Names Dr. James Jesse as Medical Director
9. Arcadia Resources Names Stephen Goldsmith to Board of Directors
10. NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations
11. Codexis Names Fernando Valle Research Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... 2014 Research and Markets ( ... "Drug Injection Devices to 2020" report ... http://photos.prnewswire.com/prnh/20130307/600769 As new drugs become ... of health conditions, drug developers have increasingly pursued ... process and increase the efficiency and reliability with ...
(Date:12/13/2014)... 12, 2014 HudsonAlpha Institute for Biotechnology ... Ten sequencing system manufactured by Illumina, Inc. (NASDQ: ... and analyze genomic data faster and at a ... commitment to research programs for genomics excellence in ... provides unprecedented capacity, speed and accuracy for sequencing ...
(Date:12/13/2014)... and INDIANAPOLIS , Dec. 12, 2014 /PRNewswire/ ... Ganassi Racing Teams (CGRT), today announced a multi-year extension of ... sponsor of the No. 83 Novo Nordisk Chip Ganassi Racing ... IndyCar Series. Kimball, 29, from ... driver with diabetes in the history of INDYCAR to win ...
Breaking Medicine Technology:Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 4Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 5Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 6Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 7
(Date:12/17/2014)... Poor students get more fruits and vegetables at school than ... the opposite is true for students from wealthier families. ... may give a healthy boost to poor students, diets, according ... income level, students all ate a similar amount of fruits ... was published recently in the journal Preventive Medicine . ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... health, but a growing body of evidence shows the ancient ... In fact, the benefits were similar to those of ... Chu, a doctoral candidate at Harvard University,s Health Policy Program ... that people randomly assigned to take yoga classes saw improvements ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Cancer researchers ... possible underlying genetic causes of deadly malignant pleural mesothelioma. ... research on their website. Click here to read ... University of Hawaii Cancer Center, and New York’s Langone ... malignant pleural mesothelioma patients in an effort to ...
(Date:12/15/2014)... Palm Beach, FL (PRWEB) December 15, 2014 ... Care , knows that holidays can be a daze of ... From slips and falls while decking halls, to burns when ... plenty of holiday hazards that can happen at any time. ... for pain, MD Now has made a list of helpful ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Health ... solutions, announced today that it has received Patient ... Assurance (NCQA) for its Disease Management (DM) Programs ... disease (COPD), coronary heart disease and diabetes. This ... NCQA for Health Dialog’s Disease Management (DM) Programs, ...
Breaking Medicine News(10 mins):Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2
... Real Parental Reassurance, NEW YORK, May 22 ... of biosensor and microprocessor technologies for,use in portable ... for its latest homecare wellness product using SPO,s ... traditional home baby,monitor market., Each year, there ...
... at ... Alma Mater, ... of two fellowships totaling $500,000,in honor of former Chief Executive Officer ... Dr. Garnier, who,received his Masters of Business Administration from the school ...
... SUPPORTS AMERICA,S NEXT GENERATION OF SCIENTISTS, WASHINGTON, ... (the Alliance) announced today the establishment of the,Alliance/Merck ... access to higher education and degrees in science,technology, ... possible,through a $4 million grant from The Merck ...
... Reach of Novel Technology, N. BILLERICA, Mass., ... of cellular bioenergetics, announced today,that Primetech Corporation will ... consumables in Japan., "Japan,s contribution to research ... have seen with the recent acquisition of Millennium ...
... 22 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, Inc. (OTC Bulletin ... leading plasma-based pharmaceutical companies in the,People,s Republic of ... from the Bureau of Health in Guangxi Province ... to a more favorable,location with a wider coverage ...
... projected to climb at double-digit rates, ... according to Millennium Research Group, WALTHAM, Mass., ... for Craniomaxillofacial (CMF) Devices 2008 report,the plate and screw fixation ... nearly $300 million in 2012, driven in part by the ...
Cached Medicine News:Health News:SPO Medical Announces Entry into the Global Baby Monitor Consumer Market 2Health News:SPO Medical Announces Entry into the Global Baby Monitor Consumer Market 3Health News:GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business 2Health News:GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business 3Health News:Alliance/Merck Ciencia (Science) Hispanic Scholars Program Announced 2Health News:Alliance/Merck Ciencia (Science) Hispanic Scholars Program Announced 3Health News:Alliance/Merck Ciencia (Science) Hispanic Scholars Program Announced 4Health News:Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 2Health News:China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma 2Health News:China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma 3Health News:Craniomaxillofacial Plate & Screw Market To Grow to Almost $300 Million by 2012 2
... is a electronic medical records software for ... The Medical Office Records does more than ... designed to follow the flow of your ... previous encounters to establishing new examination records ...
... ChartMaker is a modular, Electronic Medical Record ... Windows to create a patient chart. ChartMaker ... E & M compliant patient notes, medical reports, ... template driven, ChartMaker is designed to be installed ...
... The eCHARMS suite comprises the ... 2000 product line. Currently, there ... signature & enterprise-wide disclosure reporting. ... new HIM management tool. These ...
Clinician's Desktop provides users the tools needed to coordinate information. Utilizing client/server technology Clinicians Desktop provides users with electronic medical records....
Medicine Products: